Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

41.32
-1.1200-2.64%
Volume:305.46K
Turnover:12.62M
Market Cap:1.74B
PE:-15.20
High:42.54
Open:42.54
Low:40.76
Close:42.44
Loading ...
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2023

Major Issues Report

8-K - Current report
Dec 07, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 12, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2022

Major Issues Report

8-K - Current report